News brief
On 2026-08-17, according to Xiniu Data, Xijia Medical completed Pre-Series A financing, raising tens of millions of RMB. Investors were lead investor Guozhong (Shenzhen) Phase Three Zhongxiaoqiye Development Private Equity Investment Fund Partnership (Limited Partnership), participating investor Weilai Industry (Wuxi) Tianshi Fund Partnership (Limited Partnership), participating investor Qinzhi Capital, participating investor Huichuang Medical, participating investor Xingfu Capital. The company is a developer of AI technology for brain science.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年8月17日，据烯牛数据报道，曦嘉医疗完成Pre-A轮融资，金额数千万人民币。投资方为国中（深圳）三期中小企业发展私募股权投资基金合伙企业（有限合伙）领投，未来产业（无锡）天使基金合伙企业（有限合伙）、勤智资本、慧创医疗、兴富资本跟投。该公司为脑科学AI技术研发商。